Galecto Inc reports results for the quarter ended in June - Earnings Summary

Damora Therapeutics

01/08/2023 16:45

* Galecto Inc  GLTO.OQ  reported a quarterly adjusted loss
of 41
cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 59 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galecto Inc's reported EPS for the quarter was a loss
of 41
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Galecto Inc shares had risen by 22.2% this quarter and
gained 167.8% so far this year.
    * The company reported a quarterly loss of $10.74 million.
    * Wall Street's median 12-month price target for Galecto Inc
is
$12.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 1 at 03:44 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.59          -0.41          Beat
 Mar. 31 2023      -0.62          -0.51          Beat
 Dec. 31 2022      -0.57          -0.55          Beat
 Sep. 30 2022      -0.68          -0.54          Beat